Expertise in composite material manufacturing and CAE for Design and Validation.

The main industrial sectors of the projects in which I have participated are the automotive, aeronautics and space. The main lines of work are the manufacturing processes in composite material especially focused on rapid manufacturing processes such as direct resistive heating or the design and manufacture of molds or self-heating membranes. 

Faustino Mujika is Professor of the Department of Mechanical Engineering in the field “Mechanics of Continuum Media and Theory of Structures”in the Faculty of Engineering of Gipuzkoa, at the University of the Basque Country (UPV/EHU). He obtained the Master Degree in Mechanical Engineering in the High Technical School of Engineers of San Sebastian (University of Navarra).

With respect to undergraduate teaching, he has been involved in subjects related to Rigid Body Mechanics and Mechanics of Materials. He has also been teaching Mechanics of Composite Materials in Master studies in the Faculty of Engineering of Gipuzkoa and in the Faculty of Engineering of Bilbao. He has supervised 9 doctoral theses related to the mechanical behaviour of Composite Materials.

Concerning research activity, he has analyzed mechanical tests related to flexural behaviour of composite laminates, introducing new test methodologies and novel test methods. Simple and low cost test methods have been proposed by using more developed novel analytical methods. Nowadays he is the head of “Mechanics of Materials” Group. He has attended numerous national and international conferences. He is coauthor in more than 50 articles included in the Web of Science, 27 of them having direct relation with the 9 supervised doctoral theses.

Currently, I hold two positions:

Visiting Scholar, Dongguk University-Seoul (College of Pharmacy)

Associate Professor, Pharmaceutical Chemistry Department, Faculty of Pharmacy, Mansoura University, Egypt

01/2016 ~ Now

• Discovered 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: a new modulator for amyloid beta-induced mitochondrial dysfunction.
• Discovered 2-(4-chloro-2-aryloxyphenyl)-1,4-dihydroisoquinolin-3(2H)-ones as TSPO ligands blocking/enhancing Aβ-induced mPTP opening.
• Discovered new pyridyl/pyrazinyl thiourea derivatives as neuroprotective agents against amyloid-β-induced toxicity
• Identified Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders
• Hit discovery of 4-amino-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide: A novel EGFR inhibitor from a designed small library
• Identified 2-(3-arylureido)pyridines and 2-(3-arylureido)pyrazines as potential modulators of Aβ-induced mitochondrial dysfunction in Alzheimer's disease
• Repositioned the antipsychotic trifluoperazine into new derivatives as anti-glioblastoma agents
• Discovered 1-(3-(Benzyloxy)pyrazin-2-yl)-3-(3,4-dichlorophenyl)urea, a new blocker of Aβ-induced mPTP opening for Alzheimer’s disease
• Discovered first-in-class thiazolidinedione derivatives as irreversible allosteric IKK-β modulators.